HAN, Tae Dong,TAK, Hee Jae,KIM, Eun Kyung,CHOI, Su Bin,PARK, Sol,KIM, Dong Hoon,KIM, So Young,CHOI, Hyun Ho,KIM, Tae Wang,JU, Mi Kyeong,HA, Na Ry,LEE, Eui Chul
申请号：
AU2019237344
公开号：
AU2019237344A1
申请日:
2019.03.20
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
The present technology provides triazolone derivatives or pharmaceutically acceptable salts thereof, preparation processes thereof, pharmaceutical compositions comprising the same, and the use thereof. The triazolone derivatives or their pharmaceutically acceptable salts exhibit selective inhibitory activity on VAP-1 and therefore can be usefully applied, e.g., for the treatment and prophylaxis of nonalcoholic hepatosteatosis (NASH).
